Sherry H-Y Chou, MD, MMSc, FNCS
Education & Training
BSc, Mathematics & Physics, McGill University, 1997
MD, CM, Medicine, McGill University, 2001
Internship, Internal Medicine, Beth Israel Deaconess Medical Center, 2002
Residency, Neurology, Brigham and Women’s Hospital, Massachusetts General Hospital, 2005
Fellowship, Neurocritical Care and Vascular Neurology, Brigham and Women’s Hospital, Massachusetts General Hospital, 2007
Diploma, Leadership Program, Harvard Business School, 2010
Research, Clinical & Academic Interests
- Neurological critical care
- Subarachnoid hemorrhage, ischemic stroke and traumatic brain injury
- Recovery after subarachnoid hemorrhage
- Brain injury biomarkers
Chou SH, Feske SK, Atherton J, Konigsberg RG, De Jager PL, Du R, Ogilvy CS, Lo EH, Ning M. Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage. Journal of Investigative Medicine. 2012 Oct 1;60(7):1054-8.
Chou SH, Lan J, Esposito E, Ning M, Balaj L, Ji X, Lo EH, Hayakawa K. Extracellular mitochondria in cerebrospinal fluid and neurological recovery after subarachnoid hemorrhage. Stroke. 2017 Aug;48(8):2231-2237.
Berkowitz AL, Westover MB, Bianchi MT, Chou SH. Aspirin for secondary prevention after stroke of unknown etiology in resource-limited settings. Neurology. 2014 Sep 9;83(11):1004-11.
Berkowitz AL, Westover MB, Bianchi MT, Chou SH. Aspirin for acute stroke of unknown etiology in resource-limited settings: a decision analysis. Neurology. 2014 Aug 26;83(9):787-93.
Faculty, CRISMA Center
Allen Humphrey Excellence in Mentoring Award, University of Pittsburgh School of Medicine, 2017
Fellow of Critical Care Medicine, 2017
Society of Critical Care Medicine Neuroscience Section Research Travel Award, 2016
Fellow of the Neurocritical Care Society, 2014